glp-1 and kidneys Role of Agonists & SGLT-2 Inhibitors in Kidney Care Physiologic effects of GLP-1 (adapted

Resveratrol can also promote the production of SCFAs such as butyrate (Tain et al., 2021), which have been shown to have anti-inflammatory and anticancer properties

doi: 10.1182/blood-2004-09-3662

They also act on appetite centres in the brain, particularly the hypothalamus, to reduce hunger signals and food cravings

Therapeutic Advances in Endocrinology and Metabolism, 15, 2042018823122236720420188231222367

Conner Mertens 12:51 As always, thanks for breaking that down for us, Robert, I think theres some very valuable information in there for our listeners

Data from nationwide registers from Sweden, Denmark and Norway showed that patients initiating SGLT-2i were less likely to develop renal adverse events, such as RRT, hospitalization, or death for renal causes, compared to GLP-1RA users [37]